Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study

Joerger, M.; Burgers, S.; Baas, P.; Smit, E.; Haitjema, T.; Bard, M.; Doodeman, V.; Smits, P.; Vincent, A.; Huitema, A.; Beijnen, J.; Schellens, J.

doi:10.1002/cncr.26562

Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study

Date

2012

Authors

Joerger, M.

Burgers, S.

Baas, P.

Smit, E.

Haitjema, T.

Bard, M.

Doodeman, V.

Smits, P.

Vincent, A.

Huitema, A.

Type:

Journal article

Citation

Cancer, 2012; 118(9):2466-2475

Statement of Responsibility

Markus Joerger, Sjaak.A. Burgers, Paul Baas, Egbert F. Smit, Tjeerd J. Haitjema, Martin P. L. Bard, Valerie D. Doodeman, Paul H. M. Smits, Andrew Vincent, Alwin D. R. Huitema, Jos H. Beijnen, and Jan H. M. Schellens

DOI

10.1002/cncr.26562

Abstract

Abstract not available

Rights

Published Version

https://doi.org/10.1002/cncr.26562

Persistent link to this record

http://hdl.handle.net/2440/88091

Full item page

Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record